Back to Search
TAYLOR FIELDS, M.D.
M.D.
Ophthalmology Physician
NPI: 1942663380IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
4301511871(MI)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 2016
Research & Publications (20)
Utilizing patient satisfaction surveys to prepare for Medicaid managed care.
PMID 11217229·J Health Care Poor Underserved·2001
8-other
Rho GTPase activity modulates Wnt3a/beta-catenin signaling.
PMID 19482078·Cell Signal·2009
7-preclinical
Three-dimensional hippocampal atrophy maps distinguish two common temporal lobe seizure-onset patterns.
PMID 19054395·Epilepsia·2009
8-other
Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.
PMID 19064814·Hypertension·2009
7-preclinical
Cryoglobulinemic glomerulopathy complicating helicobacter pylori-associated gastric mucosa-associated lymphoid tissue lymphoma.
PMID 19535189·Am J Kidney Dis·2009
5-case
Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model.
PMID 19328919·Transplant Proc·2009
7-preclinical
Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration.
PMID 19095998·Arterioscler Thromb Vasc Biol·2009
7-preclinical
Opening the black box of cancer surgery quality: WebSMR and the Alberta experience.
PMID 19338026·J Surg Oncol·2009
8-other
Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2).
PMID 19556343·Mol Endocrinol·2009
7-preclinical
TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
PMID 18174241·Carcinogenesis·2008
7-preclinical
Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
PMID 17999987·Carcinogenesis·2008
7-preclinical
Gq-dependent signaling upregulates COX2 in glomerular podocytes.
PMID 18667730·J Am Soc Nephrol·2008
7-preclinical
Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.
PMID 18367845·Kidney Blood Press Res·2008
7-preclinical
Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.
PMID 17999389·Prostate·2008
7-preclinical
Increased fast ripple to ripple ratios correlate with reduced hippocampal volumes and neuron loss in temporal lobe epilepsy patients.
PMID 17662059·Epilepsia·2007
8-other
The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
PMID 17283142·Cancer Res·2007
7-preclinical
Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
PMID 17522389·Cancer Res·2007
8-other
Employing clinical decision support to attain our strategic goal: the safe care of the surgical patient.
PMID 17583164·J Healthc Inf Manag·2007
8-other
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
PMID 17936154·J Am Coll Cardiol·2007
4-observational
Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin.
PMID 16985211·Am J Physiol Renal Physiol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2799 W GRAND BLVD
DETROIT, MI 48202 - Phone
- (833) 663-7874
Quick Facts
- NPI
- 1942663380
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile